Effect of orlistat on cardiovascular disease risk in obese adults-Reference-Cited by-同舟云学术

Effect of orlistat on cardiovascular disease risk in obese adults

Published:2005-05 Issue:3 Volume:7 Page:254-262
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Swinburn B. A.,Carey D.,Hills A. P.,Hooper M.,Marks S.,Proietto J.,Strauss B. J.,Sullivan D.,Welborn T. A.,Caterson I. D.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2004.00467.x/fullpdf

Reference23 articles.

1. 1 World Health Organisation . Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Geneva, World Health Organisation, 2000 . WHO Technical Report Series 894.

2. EXERCISE IN WEIGHT MANAGEMENT OF OBESITY

3. Weight reduction and long-term maintenance after 18 months treatment with orlistat for obesity

4. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to review by Pan et al.;Obesity;2024-07-10

2. Ameliorative effects of Orlistat and metformin either alone or in combination on liver functions, structure, immunoreactivity and antioxidant enzymes in experimentally induced obesity in male rats;Heliyon;2023-08

3. Recent advancements in pharmacological strategies to modulate energy balance for combating obesity;RSC Medicinal Chemistry;2023

4. Semaglutide 2.4 Mg for the Management of Overweight and Obesity: Systematic Literature Review and Meta-Analysis;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-12

5. AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity;Gastroenterology;2022-11